MedPath

Inhaled IAV vs Inhaled Eucalyptus for the Treatment of Nausea With Acute Migraine

Not Applicable
Recruiting
Conditions
Migraine
Registration Number
NCT05175521
Lead Sponsor
HonorHealth Research Institute
Brief Summary

The goal of this study is to compare the efficacy and adverse events of inhaled isopropyl alcohol vapor (IAV) versus placebo (inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) for treating nausea associated with acute migraine attacks.

Detailed Description

The main goal of this study is to examine the efficacy of (nausea reduction and time to use of other anti-nausea medications) and side effects of inhaled isopropyl alcohol vapor (IAV) for treating nausea among migraine patients using a double blind randomized control methodology. IAV is being compared inhaled eucalyptus scent (IES) (1:20 dilution in mineral oil) which has not shown benefit for treating nausea or migraine and is therefore considered placebo in this study.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Patients 18 to 65 years old with nausea associated migraines at least twice per month
Exclusion Criteria
  • Patients <18 or >65 years old
  • Patients without a diagnosis of acute migraine

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change of Severity of Nausea on Nausea Scale½ hour or to the end of treatment

Change in Nausea, modified visual analog score from 0-10 with 10 severe nausea with vomiting, 5 moderate nausea, 1 mild nausea and 0 no nausea.

Secondary Outcome Measures
NameTimeMethod
Time to Clinically Relevant Nausea Change½ hour or to the end of treatment

Did IAV vs eucalyptus oil reduce the amount of time the patient experienced nausea with their migraine?

Side effects associated with interventional substance½ hour, but likely less than 2 hours

Patient written report

Use of anti-nausea medication/Time to use of anti-nausea medication½ hour or to the end of treatment

Did using IAV vs eucalyptus oil change the time until use of oral anti-emetic?

Trial Locations

Locations (1)

HonorHealth Bob Bové Neuroscience Institute

🇺🇸

Scottsdale, Arizona, United States

HonorHealth Bob Bové Neuroscience Institute
🇺🇸Scottsdale, Arizona, United States
Angelina Cooper
Contact
480-583-3193
ancooper@honorhealth.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.